Avidity expands its leading RNA delivery technology into precision cardiology with two new wholly-owned development candidates targeting rare genetic cardiomyopathies: AOC…
Altair software available to organizations through ESA Partnership Initiative for Commercialisation (EPIC) TROY, Mich., Nov. 12, 2024 /PRNewswire/ — Altair (Nasdaq:…